上海调查组解聘隐瞒患儿临床试验死亡以发表《自然》论文的医学研究人员
Shanghai investigators sack medical researchers who concealed child's clinical trial death to publish Nature study
- 上海市当局对新华医院两名资深研究人员作出解聘处理,两人在向《自然》(Nature)期刊发表基因编辑研究成果的过程中,蓄意隐瞒了一名儿科临床试验患者死亡的真相。 Shanghai municipal authorities dismissed two senior researchers who concealed the death of a pediatric clinical trial patient at Xinhua Hospital while publishing their gene-editing study in Nature.
- 受害患儿父母出资533.7万元资助定制碱基编辑研究,并直接向临床医生送去逾100万元现金及高档名酒;而涉事医生则蓄意隐匿了此前非人灵长类动物试验中出现的严重毒性预警。 The victim's parents paid 5.337 million yuan to fund custom base-editing research and gave over 1 million yuan in cash and luxury liquor directly to clinicians who hid preclinical primate toxicity warnings.
- 这场致命掩盖直到美国《科学》(Science)杂志刊发国际吹哨人调查、曝光患儿死亡事件后才告败露,迫使当局随后对医院伦理审查官员施加迟来的行政处罚。 The lethal cover-up unraveled only after international whistleblowing in Science magazine exposed the fatal outcome, prompting belated administrative penalties against hospital ethics officials.
据澎湃新闻报道,上海市联合调查处置工作组于11月13日发布通报,对两名隐瞒儿科临床试验死亡以换取在《自然》(Nature)发表论文的资深生物医药研究人员予以解聘。2023年7月,一名患有罕见神经发育障碍疾病的患儿父母出资533.7万元,资助上海交通大学与新华医院开展定制基因编辑研究。涉事科研人员还直接从患儿家属手中收受了106万元现金及茅台酒。临床医生无视灵长类动物实验中的毒性预警,在知情同意书中将致命风险隐匿殆尽。患儿在接受治疗七天后不幸离世。主要作者对此瞒而不报,并于次年2月将相关小鼠试验成果发表于《自然》期刊。
这起丑闻暴露出系统性的借口掩饰。医院管理者将致人死亡的人体实验粉饰为‘同情用药与关怀救治’,而科学家则趁机向绝望的父母敲诈个人利益。直至2026年7月美国《科学》(Science)杂志踢爆这桩被隐匿的死亡事件,这场瞒报才告瓦解。类似的手法并不新鲜:2018年,贺建奎在深圳规避体制规范制造基因编辑婴儿,所倚仗的正与此次批准新华医院致命试验的橡皮图章式伦理委员会如出一辙。
市级层面的纪律处分完全依赖于表演式替罪。当局解聘两名涉事学者,却让国家垄断的医疗官僚等级制与不透明的医院采购利益网络毫发无损。体制性俘获则为整套体制构筑起保护伞。党委部门将西方顶级期刊的高影响力论文置于基本临床安全之上,将试验病房变相沦为个人晋升的工具。最终付出代价的永远是普通家庭——所谓的关爱救治,早已蜕变为赤裸裸的敲诈勒索。
The Shanghai Municipal Investigation and Disposal Working Group released a circular on November 13 dismissing two senior biomedical researchers who concealed a pediatric clinical trial death to publish in Nature, The Paper reported. In July 2023, parents of a child with a rare neurodevelopmental disorder paid 5.337 million yuan to fund custom gene-editing research at Shanghai Jiao Tong University and Xinhua Hospital. Scientists pocketed an additional 1.06 million yuan in cash and Maotai liquor directly from the family. The clinicians ignored toxic warnings in primate tests, omitting fatal risks from consent forms entirely. The child died seven days later. Lead authors hid the fatality, publishing their mouse study in Nature the following February.
The scandal exposes systemic pretextual cloaking. Hospital administrators styled lethal human experimentation as compassionate care while scientists extracted personal tribute from desperate parents. The cover-up collapsed only after Science magazine revealed the hidden fatality in July 2026. The playbook is familiar. In 2018, He Jiankui bypassed institutional rules in Shenzhen to create gene-edited babies, leaning on the same rubber-stamp hospital committees that approved Xinhua Hospital’s lethal trial.
Municipal disciplinary action relies on performative scapegoating. Authorities dismissed two scientists, leaving the state-monopolized medical hierarchy and opaque hospital procurement networks completely intact. Institutional capture shields the system. Party committees reward high-profile Western publications over basic clinical safety, turning experimental wards into personal career vehicles. Ordinary families pay the price. Care turns into extortion.
调查处理通报在微博、知乎与微信上激起公愤,网民对医学科学家为追求科研声望与个人收贿、竟对绝症患儿家属巧取豪夺感到骇人听闻。评论者指出,在明知灵长类动物安全性试验已亮起严重毒性红灯的情况下,涉事人员仍照收不误106万元现金与茅台酒,手段极为冷酷残忍:“他们把一个垂死的孩子当成了换取《自然》论文发表的实验燃料。”另有评论讽刺上海官方通报,直言如果不是美国《科学》(Science)杂志率先踢爆这一死亡事件,这桩致命掩盖丑闻恐怕早已被永久埋葬在顶级期刊的学术光环之下。
The investigative findings sparked incandescent outrage across Weibo, Zhihu, and WeChat, with netizens expressing horror that medical scientists preyed on a terminally ill child's parents for research prestige and personal bribes. Commenters pointed out the grim cruelty of pocketing 1.06 million yuan in cash and Maotai while knowing that primate safety trials had flashed severe toxicity red flags: 'They treated a dying child as experimental fuel for a Nature publication.' Other commentators mocked Shanghai's official notice, observing that the lethal cover-up would have remained buried in high-impact academic glory if an American journal (*Science*) had not exposed the death first.
网信部门在微博与抖音上严厉执行信息管控与隔离,压制与“交大医学院基因编辑研究事件”及“新华医院患儿死亡”相关的热搜词条。平台算法将官方通报下方的评论区严格限制为经核准的认证账号可见,同时压制质疑医院伦理审查委员会监管缺位的独立生命伦理学评论。官方媒体接到指令,仅允许转发上海市联合调查处置工作组发布的统发通报,将事件定调为雷厉风行的行政问责,刻意淡化体制性的监管溃败。
Cyberspace authorities strictly enforced information containment across Weibo and Douyin, throttling trending hashtags related to 'Jiaotong University gene-editing death' (*交大医学院基因编辑研究事件*) and 'Xinhua Hospital child death' (*新华医院患儿死亡*). Platform algorithms restricted comment sections on official bulletins to approved verified accounts and suppressed independent bioethics commentaries that questioned oversight of hospital ethics review boards. State media outlets were directed to circulate only the standardized bulletin from the Shanghai Municipal Investigation and Disposal Working Group, framing the outcome as swift administrative accountability rather than a systemic regulatory failure.
中国在国家意志主导下争夺生物技术与基因治疗领先地位的狂飙突进,屡屡遭遇严重的伦理危机。2018年,生物物理学家贺建奎在深圳借助形同虚设的医院伦理委员会审查,利用CRISPR-Cas9技术制造基因编辑婴儿,引发国际舆论谴责。尽管此后法规有所修订,中国各临床研究机构依然充斥着利益冲突:临床科研人员向走投无路的患者索要巨额私人捐款与回扣,而医院伦理委员会则在产出高影响力科研突破的体制压力下,沦为走过场的橡皮图章。
China's state-backed rush for leadership in biotechnology and gene therapy has repeatedly collided with grave ethical failures. In 2018, biophysicist He Jiankui provoked international condemnation by using CRISPR-Cas9 to edit human embryos in Shenzhen, assisted by rubber-stamp hospital review boards. Despite subsequent regulatory revisions, Chinese clinical research centers continue to suffer from conflicts of interest where physician-scientists solicit massive private donations and kickbacks from desperate patients while hospital ethics committees operate under institutional pressure to deliver high-impact scientific breakthroughs.